Clinical Trials Logo

Hypercholesterolemia clinical trials

View clinical trials related to Hypercholesterolemia.

Filter by:

NCT ID: NCT00080275 Completed - Clinical trials for Hypercholesterolemia

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Start date: March 2004
Phase: Phase 3
Study type: Interventional

The purpose of this 24 week study is to compare the effectiveness and safety of different doses of Niacin ER/Simvastatin (NS) in subjects with elevated fat levels in their blood (dyslipidemia). At least 600 subjects with a similar medical condition will take part in this study.

NCT ID: NCT00079859 Terminated - Clinical trials for Familial Hypercholesterolemia

Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy

Start date: October 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if implitapide, used in conjunction with other lipid-lowering therapies, is safe and effective when compared to placebo in lowering low-density lipoprotein cholesterol (LDL-C) in patients with heterozygous familial hypercholesterolemia (HeFH).

NCT ID: NCT00079846 Terminated - Clinical trials for Familial Hypercholesterolemia

Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy

Start date: September 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if implitapide, used in conjunction with other lipid-lowering therapies, is safe and effective when compared to placebo in lowering low-density lipoprotein cholesterol (LDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).

NCT ID: NCT00074633 Completed - Hypertension Clinical Trials

Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model

Start date: January 2000
Phase: N/A
Study type: Interventional

Increasingly more individuals are trying to lose weight. Indeed, many women, regardless of their size, experience a life-long battle and preoccupation with their weight. Despite the attention to weight and the increase in diet behavior, the incidence of obesity continues to rise. There is little data to show improved long term success for the majority of participants who engage in weight loss behaviors. The specific aim is to improve the psychological and metabolic health of obese women with a history of chronic dieting through encouraging "Health at Every Size" (HAES). This treatment model emphasizes "intutitive eating," i.e., internal regulation of eating (responding to cues of hunger, appetite and satiety). The HAES model is being compared to the current standard of care in obesity treatment, energy restriction dieting, which encourages cognitive control of eating and weight reduction.

NCT ID: NCT00067587 Completed - HIV Infections Clinical Trials

Metabolic Abnormalities in HIV Infected and Uninfected Young Women

Start date: July 2003
Phase: N/A
Study type: Observational

Though anti-HIV drugs can dramatically improve the health of people with HIV, some people taking these drugs develop serious long term effects in their metabolism. These effects include problems with bones, increased levels of blood sugar and lipids, and changes in body fat distribution. The purpose of this study is to see how many young women are experiencing these problems and how severe the problems are. This kind of study is the first step in determining how best to treat these problems.

NCT ID: NCT00065624 Completed - Clinical trials for Hypercholesterolemia

Antioxidant Functions of Lipoic Acid

Start date: November 2003
Phase: Phase 2
Study type: Interventional

The goal of this study is to determine whether a short treatment with lipoic acid, an antioxidant used in the treatment of diabetic neuropathy, improves blood vessel reactivity and decreases oxidant stress in persons with elevated blood cholesterol.

NCT ID: NCT00056511 Completed - Clinical trials for Hypercholesterolemia

Comparing Effects of 3 Sources of Garlic on Cholesterol Levels

Start date: May 2002
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether fresh garlic can positively affect cholesterol in adults with moderately high cholesterol levels. This study will also determine whether the same effects can be found for two main types of garlic supplements: a dried powdered garlic (designed to yield the same effect as fresh garlic) and an aged garlic extract preparation.

NCT ID: NCT00051415 Completed - Clinical trials for Hypercholesterolemia

Safety and Effectiveness of Flaxseed for Reducing High Cholesterol

Start date: January 2003
Phase: Phase 2/Phase 3
Study type: Interventional

Flaxseed, a rich source of fiber, may be a significant component of a cholesterol-reducing diet. The purpose of this study is to evaluate the safety and effectiveness of flaxseed in reducing high cholesterol.

NCT ID: NCT00046267 Completed - HIV Infections Clinical Trials

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety, efficacy, and tolerability of extended-release niacin (Niaspan) in improving the level of fats in the blood of HIV-infected patients.

NCT ID: NCT00037401 Completed - Clinical trials for Cardiovascular Diseases

Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD

Start date: September 2001
Phase: N/A
Study type: Observational

To compare the effects of statin therapy alone with statin plus fibrate therapy on several emerging risk factors for atherosclerotic cardiovascular disease in a representative subgroup of the ACCORD cohort that is being followed for cardiovascular endpoints.